Recent News

• 06.04.2025 - Xenon Pharmaceuticals Annual Meeting of Shareholders
• 04.04.2025 - Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
• 04.04.2025 - Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
• 03.12.2025 - Xenon to Present at Stifel 2025 Virtual CNS Forum
• 03.12.2025 - Xenon to Present at Stifel 2025 Virtual CNS Forum
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 02.27.2025 - Q4 2024 Xenon Pharmaceuticals Inc. Earnings Conference Call
• 02.27.2025 - Q4 2024 Xenon Pharmaceuticals Inc. Earnings Conference Call
• 02.27.2025 - Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
• 02.27.2025 - Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update

Recent Filings

• 04.24.2025 - ARS Annual Report to Security Holders
• 04.24.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.24.2025 - DEF 14A Other definitive proxy statements
• 03.17.2025 - 8-K Current report
• 03.17.2025 - EX-99.1 EX-99.1
• 03.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.05.2025 - 8-K Current report